Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis

Tissue Antigens

Volumn 71, Issue 1, 2008, Pages 77-80

  Mrazek, F ^a   Kvezereli, M ^a   Garr, E ^b   Kubistova, Z ^a   Kriegova, E ^a   Fillerova, R ^a   Arakelyan, A ^a   Ruven, H J T ^c   Drabek, J ^a   Van Den Bosch, J M M ^c   Kolek, V ^a   Welsh, K I ^b   Grutters, J C ^c   Du Bois, R M ^b   Petrek, M ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

CR1; Genetics of complex diseases; Replication of a case control study; Sarcoidosis

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; LUNG ALVEOLUS CELL; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CZECH REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT 3B; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 36949003431     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00957.x     Document Type: Article

References (24)

1. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003 : 361 : 1111 8.
2. du Bois RM, Beirne PA, Anevlavis SE. Genetics. In : Drent M, Costabel U, eds. Sarcoidosis - European Respiratory Monograph Vol. 10. Sheffield: European Respiratory Journals, 2005, 64 81.
3. Iannuzzi MC. Genetics of sarcoidosis. Semin Respir Crit Care Med 2007 : 28 : 15 21.
4. Zorzetto M, Bombieri C, Ferrarotti I et al. Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002 : 27 : 17 23.
5. Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev 2001 : 180 : 112 22.
6. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986 : 164 : 50 9.
7. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998 : 87 : 176 83.
8. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999 : 160 : 736 55.
9. Okayama H, Curiel DT, Brantly ML, Holmes MD, Crystal RG. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 1989 : 114 : 105 13.
10. Lalouel JM, Rohrwasser A. Power and replication in case-control studies. Am J Hypertens 2002 : 15 : 201 5.
11. Excoffier L, Laval G, Schneider S. Arlequin version 3.0: an integrated software package for population genetics data analysis. Evol Bioinformatics Online 2005 : 1 : 47 50.
12. Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 1999 : 163 : 4939 45.
13. Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res 2000 : 10 : 1435 44.
14. Silverman EK. Haplotype thinking in lung disease. Proc Am Thorac Soc 2007 : 4 : 4 8.
15. Cockburn IA, Rowe JA. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3′ untranslated regions of the CR1 gene. Int J Immunogenet 2006 : 33 : 17 20.
16. Biglino A, Albera C, Cariti G, Gioannini P. Relationship between circulating immune complexes, serum interferon and clinical features in sarcoidosis. Respiration 1985 : 47 : 293 8.
17. Rooney DP, Finch MB, Elborn JS, Stanford CF. Circulating immune complexes in sarcoidosis, a clinical role for the Raji assay? Eur Respir J 1990 : 3 : 760 4.
18. Schoenfeld N, Schmolke B, Schmitt M et al. Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis. Thorax 1994 : 49 : 688 91.
19. Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005 : 366 : 1121 31.
20. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001 : 29 : 306 9.
21. Iannuzzi MC, Maliarik M, Rybicki BA. Nomination of a candidate susceptibility gene in sarcoidosis. The complement receptor 1 gene. Am J Respir Cell Mol Biol 2000 : 27 : 3 7.
22. Whitsett JA, Bachurski CJ, Barnes KC et al. Functional genomics of lung disease. Am J Respir Cell Mol Biol 2004 : 31 (Suppl S1 81.
23. Janssen R, Sato H, Grutters JC et al. The Clara cell10 adenine38guanine polymorphism and sarcoidosis susceptibility in Dutch and Japanese subjects. Am J Respir Crit Care Med 2004 : 170 : 1185 7.
24. Bunce M, O'Neil CM, Barnardo MCNM et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995 : 46 : 355 67.